← FDA DRUG APPROVALS

FDA ANDA · ANDA075997

MEGESTROL ACETATE

Sponsor: HIKMA

APPLICATION
ANDA075997
TYPE
ANDA
ORIGINAL APPROVAL
2002-02-15
LATEST ACTION
2020-05-18
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

MEGESTROL ACETATEDiscontinued
MEGESTROL ACETATE 40MG/ML · SUSPENSION · ORAL

Approval history

2020-05-18Labeling · Supplement 16 · standardAP
2016-02-29Labeling · Supplement 14 · standardAP
2007-10-02Labeling · Supplement 9AP
2007-05-14Labeling · Supplement 8AP
2003-06-06Labeling · Supplement 2AP
2002-02-15OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →